Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. (10th May 2020)

• Record Type: Journal Article
• Authors: Bettiol, Alessandra; Emmi, Giacomo; Finocchi, Martina; Silvestri, Elena; Urban, Maria Letizia; Mattioli, Irene; Scalera, Antonella; Lupoli, Roberta; Vannacci, Alfredo; Di Minno, Matteo Nicola Dario; Prisco, Domenico
• Is Part Of: Rheumatology. Volume 59:Number 12(2020)
• Page Start: 3709
• Page End: 3716
• Publication Date: 2020-05-10
• Subjects: antiphospholipid syndrome -- lupus anticoagulant -- pregnancy -- thrombosis -- atherosclerosis; Rheumatism -- Periodicals; Rheumatology -- Periodicals; 616.723005
• DOI: 10.1093/rheumatology/keaa116
• Languages: English
• ISSNs: 1462-0324

Abstract

Abstract: Objectives: The persistent positivity of aPLs, either isolated or associated with thrombotic and/or obstetric events (APS), has been associated with the increase of intima-media thickness (IMT) and carotid plaques. Despite the fact that aPLs can promote both thrombotic and obstetric complications, some pathogenic differences have been documented between the two entities. This study aimed to evaluate whether the atherosclerotic risk differs between subjects with obstetric and thrombotic APS. Methods: A total of 167 APS women (36 obstetric and 131 thrombotic) were compared with 250 aPLs negative controls. IMT of the common carotid artery (CCA) and of the bulb and the prevalence of carotid plaques were assessed. Results: CCA- and bulb-IMT were significantly higher in women with thrombotic APS, while being similar between the obstetric APS and the controls [CCA-IMT: mean (s .d .) 0.97 (0.49), 0.78 (0.22) and 0.81 (0.12) mm for the thrombotic, obstetric and control groups, respectively, P < 0.001 between thrombotic and controls, P = 0.002 between thrombotic and obstetric; bulb-IMT: mean (s .d .) 1.38 (0.79), 0.96 (0.27) and 0.96 (0.51) mm for the thrombotic, obstetric and control groups, P < 0.001]. Women with thrombotic APS had significantly increased risk of presenting carotid plaques. This risk was significantly lower in obstetric APS. Conclusion: Unlike thrombotic APS, obstetric APS is not associated with an increase of markers of subclinical atherosclerosis. If confirmed on wider populations, these results could suggest different pathogenetic role of aPLs in promoting atherosclerosis in vascular and obstetric APS, and raise questions on the risk–benefit profile of thromboprophylaxis in obstetric APS outside pregnancy periods.